The firm is currently reviewing the merger between First Hawaiian, Inc. and TriCo Bancshares, which would leave First Hawaiian shareholders with approximately 65% of the combined entity. Simultaneously, attorneys are examining the Indivior Pharmaceuticals, Inc. deal with Supernus Pharmaceuticals, where Indivior stakeholders are set to control 56.5% of the resulting company.

Two cash-based acquisitions are also under the firm's microscope. Integer Holdings Corporation shareholders are slated to receive $127.00 per share in their sale to KKR. Meanwhile, the Lantheus Holdings, Inc. agreement with Curium US Holdings LLC offers $102.50 per share, alongside non-transferable contingent value rights worth up to $12.00, provided specific commercial milestones are met through 2030. Monteverde & Associates, recognized in the 2025 ISS Securities Class Action Services Report, invites shareholders of these companies to review the terms of these transactions for potential legal concerns.